← Eichor
Study identifier: NCT05574517 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Condition: Urinary Calculi · Percutaneous Nephrolithotomy  ·  Sponsor: The First Affiliated Hospital of University of South China

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.

This description comes directly from the study's public registry record.

Talk to the study team

Mingyong Li, MD  ·  18175878363  ·  myli1123@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital of University of South ChinaHengyang, Hunan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05574517